$ Value
$3K
Shares
5,032
Price
$1
Filed
Feb 17
Insider
Name
Ali Faraz
Title
Chief Executive Officer
CIK
0001667937
Roles
Transaction Details
Transaction Date
2026-02-17
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
443,404
Footnotes
Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023. | Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.6075 to $0.671. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | Includes 354,250 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. | Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024. | Includes 343,625 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. | Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025. | Includes 330,187 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
Filing Info
Ali Faraz's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-17 | TNYA | ▼ | $4K |
| 2026-02-17 | TNYA | ▼ | $3K |
| 2026-02-17 | TNYA | ▼ | $3K |
| 2026-02-03 | TNYA | A | $0 |
| 2026-02-03 | TNYA | A | $0 |
| 2025-11-17 | TNYA | ▼ | $4K |
| 2025-08-18 | TNYA | ▼ | $7K |
| 2025-08-18 | TNYA | ▼ | $5K |
| 2025-08-18 | TNYA | ▼ | $6K |
| 2025-05-16 | TNYA | ▼ | $1K |
Other Insiders at TNYA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Ali Faraz
Chief Executive Officer
|
— | $6K | 2026-02-17 |
| COLUMN GROUP III GP, LP | — | $5.9M | 2026-02-25 |
|
Tingley Whittemore
Chief Medical Officer
|
— | $3K | 2026-02-17 |
|
Higa Tomohiro
SVP, Finance
|
— | $2K | 2026-02-17 |